{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:56:53Z","timestamp":1790783813205,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University of Messina Research&Mobility"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI110310"],"award-info":[{"award-number":["R01AI110310"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ejmech.2016.07.077","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T01:58:47Z","timestamp":1470275927000},"page":"673-683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Computational and synthetic approaches for developing Lavendustin B derivatives as allosteric inhibitors of HIV-1 integrase"],"prefix":"10.1016","volume":"123","author":[{"given":"Fatima E.","family":"Agharbaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley C.","family":"Hoyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Gitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosa","family":"Buemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamuka","family":"Kvaratskhelia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0614-5713","authenticated-orcid":false,"given":"Laura","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2016.07.077_bib1","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1111\/j.1742-4658.2009.07009.x","article-title":"Piecing together the structure of retroviral integrase, an important target in AIDS therapy","volume":"276","author":"Jaskolski","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2016.07.077_bib2","first-page":"93","article-title":"HIV-1 integrase multimerization as a therapeutic target","volume":"389","author":"Feng","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ejmech.2016.07.077_bib3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/13543784.2012.658914","article-title":"Elvitegravir: a once-daily inhibitor of HIV-1 integrase","volume":"21","author":"Wills","year":"2012","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ejmech.2016.07.077_bib4","series-title":"AIDS Patient Care STDS 21","first-page":"889","author":"FDA approves raltegravir tablets","year":"2007"},{"key":"10.1016\/j.ejmech.2016.07.077_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40265-013-0015-5","article-title":"Next-generation integrase inhibitors : where to after raltegravir?","volume":"73","author":"Karmon","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2016.07.077_bib6","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1021\/jm800245z","article-title":"Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection","volume":"51","author":"Summa","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.07.077_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1473-3099(11)70290-0","article-title":"Once daily dolutegravir (S\/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial","volume":"12","author":"van Lunzen","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2016.07.077_bib8","first-page":"81","article-title":"Critical appraisal of elvitegravir in the treatment of HIV-1\/AIDS, HIV","volume":"6","author":"Pandey","year":"2014","journal-title":"AIDS (Auckl)"},{"key":"10.1016\/j.ejmech.2016.07.077_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jac\/dkp153","article-title":"Evolution of raltegravir resistance during therapy","volume":"64","author":"Sichtig","year":"2009","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2016.07.077_bib10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMoa0708975","article-title":"Raltegravir with optimized background therapy for resistant HIV-1 infection","volume":"359","author":"Steigbigel","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2016.07.077_bib11","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/QAD.0b013e3283473599","article-title":"Elvitegravir overcomes resistance to raltegravir induced by integrase mutation Y143","volume":"25","author":"Metifiot","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.ejmech.2016.07.077_bib12","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/sj.emboj.7601005","article-title":"Retroviral DNA integration: reaction pathway and critical intermediates","volume":"25","author":"Li","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2016.07.077_bib13","doi-asserted-by":"crossref","first-page":"40858","DOI":"10.1074\/jbc.R112.397760","article-title":"Retroviral integrase proteins and HIV-1 DNA integration","volume":"287","author":"Krishnan","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2016.07.077_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrmicro2747","article-title":"The structural biology of HIV-1: mechanistic and therapeutic insights","volume":"10","author":"Engelman","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2016.07.077_bib15","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1074\/jbc.M209278200","article-title":"HIV-1 integrase forms stable tetramers and associates with LEDGF\/p75 protein in human cells","volume":"278","author":"Cherepanov","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2016.07.077_bib16","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nm1329","article-title":"A\u00a0role for LEDGF\/p75 in targeting HIV DNA integration","volume":"11","author":"Ciuffi","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2016.07.077_bib17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1126\/science.1132319","article-title":"An essential role for LEDGF\/p75 in HIV integration","volume":"314","author":"Llano","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2016.07.077_bib18","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1101\/gad.1565107","article-title":"LEDGF\/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration","volume":"21","author":"Shun","year":"2007","journal-title":"Genes. Dev."},{"key":"10.1016\/j.ejmech.2016.07.077_bib19","doi-asserted-by":"crossref","first-page":"17841","DOI":"10.1074\/jbc.M411681200","article-title":"The interaction of LEDGF\/p75 with integrase is lentivirus-specific and promotes DNA binding","volume":"280","author":"Busschots","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2016.07.077_bib20","first-page":"125","article-title":"Virological and cellular roles of the transcriptional coactivator LEDGF\/p75","volume":"339","author":"Llano","year":"2009","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ejmech.2016.07.077_bib21","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.tips.2007.09.005","article-title":"Blocking interactions between HIV-1 integrase and cellular cofactors: an emerging anti-retroviral strategy","volume":"28","author":"Al-Mawsawi","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2016.07.077_bib22","doi-asserted-by":"crossref","first-page":"e1000046","DOI":"10.1371\/journal.ppat.1000046","article-title":"The lentiviral integrase binding protein LEDGF\/p75 and HIV-1 replication","volume":"4","author":"Engelman","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2016.07.077_bib23","doi-asserted-by":"crossref","first-page":"48883","DOI":"10.1074\/jbc.M406307200","article-title":"Identification of an evolutionarily conserved domain in human lens epithelium-derived growth factor\/transcriptional co-activator p75 (LEDGF\/p75) that binds HIV-1 integrase","volume":"279","author":"Cherepanov","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2016.07.077_bib24","doi-asserted-by":"crossref","first-page":"17308","DOI":"10.1073\/pnas.0506924102","article-title":"Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75","volume":"102","author":"Cherepanov","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2016.07.077_bib25","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nchembio.370","article-title":"Rational design of small-molecule inhibitors of the LEDGF\/p75-integrase interaction and HIV replication","volume":"6","author":"Christ","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2016.07.077_bib26","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1021\/ml500002n","article-title":"Discovery of BI 224436, a Noncatalytic site integrase inhibitor (NCINI) of HIV-1","volume":"5","author":"Fader","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2016.07.077_bib27","doi-asserted-by":"crossref","first-page":"21189","DOI":"10.1074\/jbc.M112.347534","article-title":"New class of HIV-1 integrase (IN) inhibitors with a dual mode of action","volume":"287","author":"Tsiang","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2016.07.077_bib28","doi-asserted-by":"crossref","first-page":"e1004171","DOI":"10.1371\/journal.ppat.1004171","article-title":"A\u00a0new class of multimerization selective inhibitors of HIV-1 integrase","volume":"10","author":"Sharma","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2016.07.077_bib29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1742-4690-10-144","article-title":"Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage","volume":"10","author":"Le Rouzic","year":"2013","journal-title":"Retrovirology"},{"key":"10.1016\/j.ejmech.2016.07.077_bib30","doi-asserted-by":"crossref","first-page":"e103552","DOI":"10.1371\/journal.pone.0103552","article-title":"The allosteric HIV-1 integrase inhibitor BI-D affects virion maturation but does not influence packaging of a functional RNA genome","volume":"9","author":"van Bel","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2016.07.077_bib31","doi-asserted-by":"crossref","first-page":"17308","DOI":"10.1073\/pnas.0506924102","article-title":"Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75","volume":"102","author":"Cherepanov","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2016.07.077_bib32","doi-asserted-by":"crossref","first-page":"16801","DOI":"10.1074\/jbc.M112.354373","article-title":"A\u00a0multimode, cooperative mechanism of action of allosteric HIV-1 integrase inhibitors","volume":"287","author":"Kessl","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2016.07.077_bib33","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1017\/erm.2013.15","article-title":"Multimodal mechanism of action of allosteric HIV-1 integrase inhibitors","volume":"15","author":"Jurado","year":"2013","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.ejmech.2016.07.077_bib34","doi-asserted-by":"crossref","first-page":"8690","DOI":"10.1073\/pnas.1300703110","article-title":"Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation","volume":"110","author":"Jurado","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2016.07.077_bib35","doi-asserted-by":"crossref","first-page":"e74163","DOI":"10.1371\/journal.pone.0074163","article-title":"Non-catalytic site HIV-1 integrase inhibitors disrupt core maturation and induce a reverse transcription block in target cells","volume":"8","author":"Balakrishnan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2016.07.077_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1742-4690-10-57","article-title":"LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions","volume":"10","author":"Desimmie","year":"2013","journal-title":"Retrovirology"},{"key":"10.1016\/j.ejmech.2016.07.077_bib37","doi-asserted-by":"crossref","first-page":"9765","DOI":"10.1128\/JVI.01522-15","article-title":"Distribution and redistribution of HIV-1 Nucleocapsid protein in immature, mature, and integrase-inhibited virions: a role for integrase in maturation","volume":"89","author":"Fontana","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2016.07.077_bib38","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1021\/acschembio.6b00167","article-title":"The competitive interplay between allosteric HIV-1 integrase inhibitor BI\/D and LEDGF\/p75 during the early stage of HIV-1 replication adversely affects inhibitor potency","volume":"11","author":"Feng","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2016.07.077_bib39","doi-asserted-by":"crossref","first-page":"15813","DOI":"10.1074\/jbc.M112.443390","article-title":"The A128T resistance mutation reveals aberrant protein multimerization as the primary mechanism of action of allosteric HIV-1 integrase inhibitors","volume":"288","author":"Feng","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2016.07.077_bib40","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12977-014-0100-1","article-title":"The mechanism of H171T resistance reveals the importance of N inverted question mark -protonated His171 for the binding of allosteric inhibitor BI-D to HIV-1 integrase","volume":"11","author":"Slaughter","year":"2014","journal-title":"Retrovirology"},{"key":"10.1016\/j.ejmech.2016.07.077_bib41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/np200906s","article-title":"Natural products as sources of new drugs over the 30 years from 1981 to 2010","volume":"75","author":"Newman","year":"2012","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2016.07.077_bib42","doi-asserted-by":"crossref","first-page":"E239","DOI":"10.1007\/BF02854894","article-title":"Drug discovery from natural sources","volume":"8","author":"Chin","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.ejmech.2016.07.077_bib43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ejmech.2013.07.025","article-title":"New scaffolds of natural origin as Integrase-LEDGF\/p75 interaction inhibitors: virtual screening and activity assays","volume":"68","author":"De Luca","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.07.077_bib44","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3109\/14756366.2012.703184","article-title":"Fragment hopping approach directed at design of HIV IN-LEDGF\/p75 interaction inhibitors","volume":"28","author":"De Luca","year":"2013","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.07.077_bib45","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1016\/j.bmc.2015.04.072","article-title":"Optimization of rhodanine scaffold for the development of protein-protein interaction inhibitors","volume":"23","author":"Ferro","year":"2015","journal-title":"Bioorg Med. Chem."},{"key":"10.1016\/j.ejmech.2016.07.077_bib46","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2016.07.077_bib47","series-title":"AMBER 11","author":"Case","year":"2010"},{"key":"10.1016\/j.ejmech.2016.07.077_bib48","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1021\/ci300361e","article-title":"Insight into the fundamental interactions between LEDGF binding site inhibitors and integrase combining docking and molecular dynamics simulations","volume":"52","author":"De Luca","year":"2012","journal-title":"J.\u00a0Chem. Inf. Model"},{"key":"10.1016\/j.ejmech.2016.07.077_bib49","unstructured":"D.S. Accelrys."},{"key":"10.1016\/j.ejmech.2016.07.077_bib50","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/ar000033j","article-title":"Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models","volume":"33","author":"Kollman","year":"2000","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2016.07.077_bib51","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/jmbi.1998.2002","article-title":"Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: high level of similarity of the active site with other viral integrases","volume":"282","author":"Maignan","year":"1998","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2016.07.077_bib52","unstructured":"v.S.L.N.Y. Maestro, NY, 2009."},{"key":"10.1016\/j.ejmech.2016.07.077_bib53","unstructured":"D.A.D. Case, T. A.; Cheatham, T. E.; III; Simmerling, C. L.; Wang, J.; Duke, R. E.; Luo, R.; Walker, R. C.; Zhang, W.; Merz, K. M.; Roberts, B.; Wang, B.; Hayik, S.; Roitberg, A.; Seabra, G.; Kolossv\u00e1ry, I.; Wong, K. F.; Paesani, F.; Vanicek, J.; Liu, J.; Wu, X.; Brozell, S. R.; Steinbrecher, T.; Gohlke, H.; Cai, Q.; Ye, X.; Wang, J.; Hsieh, M.-J.; Cui, G.; Roe, D. R.; Mathews, D. H.; Seetin, M. G.; Sagui, C.; Babin, V.; Luchko, T.; Gusarov, S.; Kovalenko, A.; Kollman, P. A.; University of California: San Francisco, 2010."},{"key":"10.1016\/j.ejmech.2016.07.077_bib54","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/jcc.10349","article-title":"A\u00a0point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations","volume":"24","author":"Duan","year":"2003","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2016.07.077_bib55","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2016.07.077_bib56","series-title":"DeLano Scientific LLC, The PyMOL Molecular Graphics System, San Carlos, CA, USA","author":"DeLano","year":"2008"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416306420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416306420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T10:51:51Z","timestamp":1536490311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523416306420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":56,"alternative-id":["S0223523416306420"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.07.077","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational and synthetic approaches for developing Lavendustin B derivatives as allosteric inhibitors of HIV-1 integrase","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.07.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}